TC BioPharm

TC BioPharm

Biotechnology Research

Holytown, North Lanarkshire 7,504 followers

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP

About us

TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Holytown, North Lanarkshire
Type
Public Company
Founded
2014
Specialties
Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine

Locations

  • Primary

    Maxim 1, 2 Parklands Way

    Eurocentral

    Holytown, North Lanarkshire ML1 4WR, GB

    Get directions

Employees at TC BioPharm

Updates

Similar pages

Browse jobs

Funding

TC BioPharm 15 total rounds

Last Round

Post IPO equity

US$ 6.0M

See more info on crunchbase